Skip to main content

cyp3a4

cyp3a4: 1 clinical trial tracked.

cyp3a4 evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about cyp3a4, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trial Registry Records (1)

A Multi-center, Open-label, Drug-drug Interaction Study to Evaluate the Effect of Pralsetinib (Gavreto) on the Pharmacokinetics of CYP3A4, CYP2C8, and CYP2C9 Substrates, and Hormones Estradiol/Norethisterone Acetate in Patients With Advanced or Metastatic Solid Tumors

NCT07704658Registry updated 2026-08-10·Phase 4·RIGL
Recruiting

Primary endpoint: Area Under the Plasma Concentration-Time Curve from zero to infinity (AUC0-inf)

Interventionalopen12 targetStarted 2026-03Completion 2027-082 sites · SpainRigel Pharmaceuticals